July 11, 2025 11:07 AM EDT
News Briefing

Man­u­fac­tur­ing lay­offs at Paci­ra; Oak Hill Bio’s Phase 1 An­gel­man da­ta

ENDPOINTS

Plus, news about Mile­stone Phar­ma:

Paci­ra Bio­Sciences cuts man­u­fac­tur­ing staff: The com­pa­ny is lay­ing off 71 em­ploy­ees at its Sci­ence Cen­ter Cam­pus in San …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Prasad again over­rode FDA vac­cine re­view­ers, this time on Mod­er­na’s Covid shot for young kids

Mer­ck­'s PD-1xVEGF part­ner LaNo­va gets snapped up for $951M

FDA ques­tions safe­ty, ef­fi­ca­cy of GSK's Blenrep in mul­ti­ple myelo­ma ahead of ad­comm

The Trump ad­min­is­tra­tion dis­band­ed a new­born screen­ing pan­el. Ad­vo­cates now face a hard­er path

Up­dat­ed: Af­ter Phase 3 obe­si­ty suc­cess, Hen­grui plans Chi­na ap­proval fil­ing for Kail­era-part­nered drug

BMS warns against ‘in­dis­crim­i­nate use’ of rene­go­ti­a­tions as CMS plans next drug price talks

A service from the Financial Times